Denosumab, sold under the brand names Prolia among others, is a human monoclonal antibody used for the treatment of osteoporosis, treatment-induced bone loss, metastases to bone, and giant cell tumor of bone.

Jul 1, 2024 · It is used to prevent bone problems in patients with multiple myeloma and bone metastases (cancer that has spread) from tumors. Denosumab is also used to treat giant cell tumor of the bone that cannot be removed by surgery.

DENOSUMAB (den oh sue mab) slows bone breakdown. Prolia is used to treat osteoporosis in women after menopause and in men, and in people who are taking corticosteroids for 6 months or more.

May 29, 2024 · Prolia (denosumab) is an injection that is administered subcutaneously (under the skin) once every 6 months by a healthcare provider to: Increase bone mass in women at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer. Bone is always breaking down and reforming.

Jan 21, 2024 · What is denosumab? The Prolia brand of denosumab is used in adults to treat osteoporosis or bone loss in people who: are at high risk for broken bones; and. who cannot use another osteoporosis medicine or these medicines did not work well. Prolia is sometimes used in people whose bone fracture is caused by certain medicines or cancer treatments.

Feb 28, 2024 · Denosumab is a bone anti-resorptive drug used for the treatment of the following: FDA-Approved Indications. Prevention of skeletal-related events: Denosumab is indicated for bone pain and fractures secondary to multiple myeloma or bone metastases from solid tumors. Used in conjunction with treatments for primary malignancy. [1] .

Dec 28, 2023 · Learn about the side effects of denosumab, from common to rare, for consumers and healthcare professionals.

Jul 3, 2024 · What is Prolia used for? Prolia (denosumab) is commonly used to treat osteoporosis, a condition in which the bones are thinner, weaker, and more prone to breakage. Prolia may be prescribed for...

When a denosumab injection product (Prolia, Jubbonti) is used to treat osteoporosis or bone loss, it is usually given once every 6 months. When a denosumab injection product (Wyost, Xgeva) is used to reduce the risk of fractures from multiple myeloma, or cancer that has spread to the bones, it is usually given once every 4 weeks.

Prolia ® is a prescription medicine used to treat osteoporosis in women after menopause who are at high risk for fracture or cannot use another osteoporosis medicine or other osteoporosis medicines did not work well. Read More. This site is for U.S. residents only. Is Prolia® Right for Me? Is Prolia right for me?